Navigation Links
The US Drug Watchdog Now Urges Young Women Who Suffered a Heart Attack or Blood Clotting After Taking Yaz or Yasmin Birth Control Pills to Contact the Johnson Law Group
Date:1/31/2013

(PRWEB) January 31, 2013

The US Drug Watchdog is now saying, "We have heard from women from all over the world related to our efforts to identify victims of severe medical side effects, who were also using the birth control pills called Yaz, Yasmin, or the generic version of these birth control pills called Ocella. In some instances the victims were in their teens, and they were using these birth control pills for acme issues. Unfortunately the medical side effects we are talking about include a pulmonary embolism, a heart attack, stroke, blood clotting, or other severe medical complications. Further, there has not been much publicity about these birth control pills, and possible severe medical complications, so we are asking mothers, sisters, friends, or loved ones, to ask any young woman who had an out of the blue stroke, heart attack, pulmonary embolism, or blood clotting, if she was also using these specific types of birth control pills. If the answer is yes, we want the victim, or their family members to contact the Johnson Law Group."

As a background, in September of 2009, the US FDA released a warning letter sent to Bayer Pharmaceuticals over Yaz & Yasmin. The letter indicates that the drug maker hid out-of-specification test results for key ingredients in the birth control pills. Out of fear the time to get identified will come, and go the US Drug Watchdog is urging women who used the birth control pills called Yaz, Yasmin, or their generic version Ocella, and then suffered severe side effects such as a pulmonary embolism, a heart attack, a stroke, a blood clot, or other severe medical conditions to contact the Johnson Law Group at 1-800-996-9900 for a evaluation of their legal rights. http://www.johnsonlawgroup.com/

The US Drug Watchdog says the following side effects have been associated Yaz, Yasmin, or Ocella:
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Urges The All US Recipients of a Metal Hip Implant To Get A Blood Test For Metals Levels and They Offer To Help All Victims Get To The Best Law Firms
2. US Drug Watchdog Now Urges Family Members Of Diabetics Who Used the Diabetes Drug Actos and Then Were Diagnosed with Bladder Cancer to Call The Johnson Law Group ASAP
3. US Drug Watchdog Now Urges Victims Of A Severe Transvaginal Mesh Product Failure To Call Them If Their Doctor Ignored Them And Offers The Names Of Top Women Lawyers
4. US Drug Watchdog Now Urges All DePuy Pinnacle Metal Hip Implant Recipients To Get A Blood Test for Cobalt and Chromium Levels Because Of Growing Worries Of Side Effects
5. US Drug Watchdog Now Urges All Metal Hip Implant Recipients to Get a Blood Test for Elevated Metals Levels Out of Fear of Side Effects Related to Cobalt or Chromium
6. US Drug Watchdog is Now Urging Bladder Cancer Victims to Call the Johnson Law Group if They Used Diabetes Drug Called Actos Prior to Diagnosis
7. US Drug Watchdog Now Urges All Women Stuck with a Failed Transvaginal Mesh Product Failure to Call Them for Names of National Caliber Attorneys
8. US Drug Watchdog Now Expands Their DePuy Pinnacle All Metal Hip Implant Initiative with Emphasis on Senior Citizens and Getting a Blood Test for Cobalt and Chromium
9. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
10. US Drug Watchdog Now Urges Transvaginal Mesh, Tape, or Bladder Sling Failure Victims To Call Them For the Names of Top Plaintiffs Women Attorneys--Erosion Is Not Normal
11. US Drug Watchdog Now Urges All US Recipients of All Metal Hip Implants to Get a Blood Test For Cobalt-Chromium Levels and They Offer Specific Law Firms For Failure Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Washington, PA (PRWEB) May 29, 2015 ... ” quiz-based learning in 14 medical specialties, now offers ... includes a wide spectrum of rheumatology disorders ranging from ... Alfred Saint Jacques, editorial director of MDLinx, and Caroline ... excited about the impact it will have on the ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 The ... greatly in the last decade. New and more efficient methods ... hair available to balding patients. One of the most cutting ... Parsa Mohebi Hair Restoration is the technique of extracting hair ... to scalp transplants are performed to correct male pattern ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and her son, yet ... does no wrong. , It’s fitting, then, that her new ... “God Does No Wrong.” It focuses on what happens when ... , “My story has a positive message about channeling the ... something healing,” Howse said. , “God Does No Wrong” immortalizes ...
(Date:5/29/2015)... May 29, 2015 World Patent Marketing, ... announces that it has signed a 10 year licensing ... that aims to let people learn about any topic ... time. , "This is an exciting day for World ... Scott J. Cooper, CEO and Creative Director of World ...
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 Mediaplanet ... the “beauty of protection”. Skin Health is a ... Today within the markets of New York, Los Angeles, ... estimated 750,000 readers. Its digital counterpart will reach a ... hubs. To read more the Skin Health campaign and ...
Breaking Medicine News(10 mins):Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Turning grief from a child’s passing into virtue 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2
... Program Offered to Local Seniors, SAN FRANCISCO, ... have,the opportunity to exercise their brains through the ... through a partnership with San,Francisco-based Posit Science. The ... mental processing, memory and other cognitive functions,with participants ...
... rhythms, helped with depression, agitation in elderly , , TUESDAY, ... lighting may ease some of the behavioral problems associated ... melatonin, a hormone which seems to play a role ... at night. , Both strategies could greatly improve quality ...
... Lose $96.7 Million in Economic Activity, $45.5 Million,in ... American Health Care,Association (AHCA) today released a new ... million (national) Medicare Part A,nursing home funding cuts ... essential health benefits in the year ahead, but ...
... CHAPEL HILL, N.C., June 10 Highly ... turnover and boost,corporate performance reside in less ... member-driven research study conducted by Best Practices,LLC,s ... satisfaction and engagement metrics and,ensure employees know ...
... old Mark Rohner of,London, Ohio, the amputation of his right ... a medical drama. During the operation in 2006, the saw,the ... knee, broke,while cutting into the bone. Like in the best ... a neighboring hospital for a,replacement saw to complete the job., ...
... doctors with patients of both races still showed disparities in ... shows that black patients with diabetes tend to fare worse ... doctor. , In other words, the gap can,t be explained ... disparities in diabetes care appear to be more the result ...
Cached Medicine News:Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 2Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 3Health News:Adding Light Eases Behavioral Problems of Dementia 2Health News:Adding Light Eases Behavioral Problems of Dementia 3Health News:New PA Economic Study: Bush Medicare Cuts Compound State Medicaid Crisis 2Health News:Best-in-Class Engagement Programs: Employees See Link Between Quality & Performance 2Health News:Gunther von Hagens' BODY WORLDS Exhibitions Welcome Specimens From World's First Living Body Donor for Plastination 2Health News:Gunther von Hagens' BODY WORLDS Exhibitions Welcome Specimens From World's First Living Body Donor for Plastination 3Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 2Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 3
(Date:5/29/2015)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the ... commercializing proven cancer therapies in new orphan drug ... American Association of Cancer Research (AACR) Advances in ... for its lead product candidate VAL-083 ...
(Date:5/29/2015)... prostate surgeon and New York Urologist, Dr. David Samadi ... Fusion-Guided Biopsy for detecting aggressive prostate cancer . ... Lenox Hill Hospital is the only center using the revolutionary ... City . We,ve seen tremendous improvement in detecting and ... an MRI makes for a much more accurate diagnosis, especially ...
(Date:5/28/2015)... and HOUSTON , May 28, ... (TSX-V: EPI) today reported financial results for the second quarter ... unless specified otherwise, are expressed in Canadian dollars and in ... Summary Results ESSA recorded a net loss ... months ended March 31, 2015 (Q2-2015), compared to a net ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 31, 2010 ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse = function(data) ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var ...
... Inc. (Nasdaq: BNVI, BNVID) announced today that it has ... Administration (FDA) regarding the Company,s Chemistry, Manufacturing and Controls ... FDA indicated its agreement with Bionovo,s plan. This agreement ... to pivotal phase 3 clinical testing. Menerba ...
Cached Medicine Technology:Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 2Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 3Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 4Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 5Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 6Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 7Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 8Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 9Bionovo Receives Positive Guidance from FDA on Menerba® 2Bionovo Receives Positive Guidance from FDA on Menerba® 3
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
... Stepper, a lightweight, easy-to-use repeater ... up to 45 times in ... Stepper handle is adapted for ... a dispensing volume range from ...
... The Repeater Plus, a handheld manual dispenser, ... time on long series pipetting. Its increased ... support for research tasks, and its smooth ... repetitive work. The nine Combitips allow a ...
... of its kind, the noncontact EnSite ... cardiac electrical information, translating it into ... electrodes, this unique tool simplifies ablation ... points of electrical data in a ...
Medicine Products: